Literature DB >> 19535965

Nomenclature for alleles of the cytochrome P450 oxidoreductase gene.

Sarah C Sim, Walter L Miller, Xiao-Bo Zhong, Wiebke Arlt, Tsutomu Ogata, Xinxin Ding, C Roland Wolf, Christa E Flück, Amit V Pandey, Colin J Henderson, Todd D Porter, Ann K Daly, Daniel W Nebert, Magnus Ingelman-Sundberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19535965      PMCID： PMC2753199          DOI： 10.1097/FPC.0b013e32832af5b7

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  15 in total

1.  Trapezoidocephaly, midfacial hypoplasia and cartilage abnormalities with multiple synostoses and skeletal fractures.

Authors:  R Antley; D Bixler
Journal:  Birth Defects Orig Artic Ser       Date:  1975

2.  Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis.

Authors:  Ningwu Huang; Amit V Pandey; Vishal Agrawal; William Reardon; Pablo D Lapunzina; David Mowat; Ethylin Wang Jabs; Guy Van Vliet; Joseph Sack; Christa E Flück; Walter L Miller
Journal:  Am J Hum Genet       Date:  2005-03-25       Impact factor: 11.025

3.  Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone.

Authors:  Keiko Homma; Tomonobu Hasegawa; Toshiro Nagai; Masanori Adachi; Reiko Horikawa; Ikuma Fujiwara; Toshihiro Tajima; Ryoujun Takeda; Maki Fukami; Tsutomu Ogata
Journal:  J Clin Endocrinol Metab       Date:  2006-04-11       Impact factor: 5.958

4.  Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients.

Authors:  Maki Fukami; Reiko Horikawa; Toshiro Nagai; Toshiaki Tanaka; Yasuhiro Naiki; Naoko Sato; Torayuki Okuyama; Hideo Nakai; Shun Soneda; Katsuhiko Tachibana; Nobutake Matsuo; Seiji Sato; Keiko Homma; Gen Nishimura; Tomonobu Hasegawa; Tsutomu Ogata
Journal:  J Clin Endocrinol Metab       Date:  2004-10-13       Impact factor: 5.958

5.  Impairment of human CYP1A2-mediated xenobiotic metabolism by Antley-Bixler syndrome variants of cytochrome P450 oxidoreductase.

Authors:  Michel Kranendonk; Christopher C Marohnic; Satya P Panda; Maria Paula Duarte; José Santos Oliveira; Bettie Sue Siler Masters; José Rueff
Journal:  Arch Biochem Biophys       Date:  2008-04-20       Impact factor: 4.013

6.  Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley-Bixler syndrome.

Authors:  Masanori Adachi; Katsuhiko Tachibana; Yumi Asakura; Toshiyuki Yamamoto; Keiichi Hanaki; Akira Oka
Journal:  Am J Med Genet A       Date:  2004-08-01       Impact factor: 2.802

7.  Abnormal sterol metabolism in a patient with Antley-Bixler syndrome and ambiguous genitalia.

Authors:  Richard I Kelley; Lisa E Kratz; Rivka L Glaser; Michael L Netzloff; Linda Miller Wolf; Ethylin W Jabs
Journal:  Am J Med Genet       Date:  2002-06-15

8.  POR R457H is a global founder mutation causing Antley-Bixler syndrome with autosomal recessive trait.

Authors:  Masanori Adachi; Yumi Asakura; Mari Matsuo; Toshiyuki Yamamoto; Keiichi Hanaki; Wiebke Arlt
Journal:  Am J Med Genet A       Date:  2006-03-15       Impact factor: 2.802

9.  Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study.

Authors:  Wiebke Arlt; Elizabeth A Walker; Nicole Draper; Hannah E Ivison; Jon P Ride; Fabian Hammer; Susan M Chalder; Maria Borucka-Mankiewicz; Berthold P Hauffa; Ewa M Malunowicz; Paul M Stewart; Cedric H L Shackleton
Journal:  Lancet       Date:  2004-06-26       Impact factor: 79.321

10.  Biochemical diagnosis of Antley-Bixler syndrome by steroid analysis.

Authors:  Cedric Shackleton; Josep Marcos; Ewa M Malunowicz; Maria Szarras-Czapnik; Petr Jira; Norman F Taylor; Nuala Murphy; Ellen Crushell; Michael Gottschalk; Berthold Hauffa; Deborah L Cragun; Robert J Hopkin; Masanori Adachi; Wiebke Arlt
Journal:  Am J Med Genet A       Date:  2004-07-30       Impact factor: 2.802
View more
  13 in total

Review 1.  Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment.

Authors:  Cristina Rodriguez-Antona; Alvin Gomez; Maria Karlgren; Sarah C Sim; Magnus Ingelman-Sundberg
Journal:  Hum Genet       Date:  2009-10-08       Impact factor: 4.132

2.  Identification of cytochrome P450 oxidoreductase gene variants that are significantly associated with the interindividual variations in warfarin maintenance dose.

Authors:  Xiuling Zhang; Lei Li; Xinxin Ding; Laurence S Kaminsky
Journal:  Drug Metab Dispos       Date:  2011-05-11       Impact factor: 3.922

3.  Influence of genetic polymorphisms in cytochrome P450 oxidoreductase on the variability in stable warfarin maintenance dose in Han Chinese.

Authors:  Wu-Tao Zeng; Qing Xu; Cheng-Hsun Li; Wei-Yan Chen; Xiu-Ting Sun; Xiang Wang; Yi-Ying Yang; Hui Shi; Zhi-Sheng Yang
Journal:  Eur J Clin Pharmacol       Date:  2016-08-04       Impact factor: 2.953

Review 4.  Databases in the area of pharmacogenetics.

Authors:  Sarah C Sim; Russ B Altman; Magnus Ingelman-Sundberg
Journal:  Hum Mutat       Date:  2011-04-05       Impact factor: 4.878

5.  Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase.

Authors:  Vishal Agrawal; Ji Ha Choi; Kathleen M Giacomini; Walter L Miller
Journal:  Pharmacogenet Genomics       Date:  2010-10       Impact factor: 2.089

6.  Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro.

Authors:  Duanpen Sandee; Kari Morrissey; Vishal Agrawal; Harrison K Tam; Melissa A Kramer; Timothy S Tracy; Kathleen M Giacomini; Walter L Miller
Journal:  Pharmacogenet Genomics       Date:  2010-11       Impact factor: 2.089

7.  The Human Cytochrome P450 (CYP) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effects.

Authors:  Sarah C Sim; Magnus Ingelman-Sundberg
Journal:  Hum Genomics       Date:  2010-04       Impact factor: 4.639

8.  Influence of various polymorphic variants of cytochrome P450 oxidoreductase (POR) on drug metabolic activity of CYP3A4 and CYP2B6.

Authors:  Xuan Chen; Li Qiang Pan; Hua Naranmandura; Su Zeng; Shu Qing Chen
Journal:  PLoS One       Date:  2012-06-12       Impact factor: 3.240

Review 9.  Pharmacogenomics of human P450 oxidoreductase.

Authors:  Amit V Pandey; Patrick Sproll
Journal:  Front Pharmacol       Date:  2014-05-09       Impact factor: 5.810

10.  Editorial: Role of Protein-Protein Interactions in Metabolism: Genetics, Structure, Function.

Authors:  Amit V Pandey; Colin J Henderson; Yuji Ishii; Michel Kranendonk; Wayne L Backes; Ulrich M Zanger
Journal:  Front Pharmacol       Date:  2017-11-27       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.